Patient beliefs about chemotherapy, cancer influence care choices at the end of life
the ONA take:
In an assessment of the impact of patients’ beliefs on their choices for care at the end of life, researchers found that patients with advanced cancer who believed chemotherapy might cure their cancer were more likely to receive chemotherapy in the last month of life and less likely to enroll in hospice care before death.
The study examined 722 patients with stage IV lung or colorectal cancer who completed a baseline survey and died during the study period.
The association of understanding goals for chemotherapy with its use in the last month of life and hospice enrollment before death was assessed using logistic regression. One-third of the patients understood that chemotherapy was “not at all” likely to cure their cancer.
However, use of chemotherapy among these patients was similar to that of other patients at end of life.
The study concludes that patients with advanced cancer who were well informed about chemotherapy's goals received late-life chemotherapy at rates similar to those for other patients. However, understanding the incurable nature of cancer is associated with increased hospice enrollment before death.
Patients with advanced cancer who believed chemotherapy might cure their cancer were more likely to receive chemotherapy.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- A Call for More Tailored Cancer Education Programs to Improve Screening
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|